Clinical Trial Update: The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial update describes evaluating the biomarker AKR1B10 for monitoring postoperative recurrence of hepatocellular carcinoma; the study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Status: NOT_YET_RECRUITING